12.5 Companies within and outside the Kingdom in which a Board
member is a manager or a member of their current or previous Board
Category |
Term |
Name |
Other joint stock companies of which
the Directors are Board Members |
Type |
Non-Executive Director |
Period from
11 May 2020 to
10 May 2023 |
Mr Hesham Al-Shaikh
Chairman of the
Board of Directors |
Watan First Institute |
Limited Company |
Mekyal Financial Tech |
Limited Company |
Probitas Holdings (Bermuda) Ltd. |
Closed Joint
Stock Company |
Ashmore Investment KSA (Previous) |
Closed Joint
Stock Company |
Bank Al-Jazira (Previous) |
Joint Stock Company |
Arab National Bank (Previous) |
Joint Stock Company |
Non-Executive Director |
Period from
11 May 2020 to
10 May 2023 |
Mr Mishari Al-Hussain
Vice-Chairman |
Doroob for Education and
Training Company |
Governmental Company |
Hana Water Company |
Private Company |
Saudi Investment Bank (Previous) |
Joint Stock Company |
Saudi Fund for Development (Previous) |
Governmental |
Aloula Real Estate Development Company (Previous) |
Closed Joint
Stock Company |
Bank Al-Jazira (Previous) |
Joint Stock Company |
Non-Executive Director |
Period from
11 May 2020 to
10 May 2023 |
Mr Ahmed Sabbagh |
Islamic Insurance Company
(Jordan) (Previous) |
Limited Joint
Stock Company |
Tunisia Takaful Insurance Company –
Tunisia (Previous) |
Joint Stock Company |
Al Aman Takaful Insurance –
Beirut (Previous) |
Closed Joint
Stock Company |
The International Federation of Takaful and Islamic Insurance Companies – Sudan (Previous) |
Federation |
Non-Executive Director |
Period from
11 May 2020 to
10 May 2023 |
Mr Jean-Luc
Gourgeon |
JLG Consulting Ltd. |
Limited Company |
ARAPL Ile de France |
Closed Joint
Stock Company |
Probitas Holdings (Bermuda) Ltd. |
Closed Joint
Stock Company |
Probitas Corporate Capital Limited |
Closed Joint
Stock Company |
Probitas Holdings UK Ltd. |
Closed Joint
Stock Company |
Probitas 1492 Services Ltd. |
Closed Joint
Stock Company |
Probitas Managing Agency
Services Ltd. |
Closed Joint
Stock Company |
Paris Re Holdings Ltd. –
France (Previous) |
Closed Joint
Stock Company |
GTT Company – France (Previous) |
Closed Joint
Stock Company |
Cunningham Lindsey Group –
USA (Previous) |
Closed Joint
Stock Company |
Paris Diderot University –
France (Previous) |
Limited Company |
French reinsurance association –
France (Previous) |
Joint Stock Company |
French reinsurance association –
France (Previous) |
Governmental |
Independent |
Period from
11 May 2020 to
10 May 2023 |
Mr Marc Maupoux |
EXIN Re AG, Zurich, Switzerland (Previous) |
|
Axis Re Zurich, Switzerland (Previous) |
|
Independent |
Period from
11 May 2020 to
10 May 2023 |
Mr Mohammad
Omair Al-Otaibi |
Zimeen Digital Marketing |
Limited Liability Company |
Al Mojel Trading and Contraction Co.
(Audit Comm Member) |
Closed Joint Stock Company |
Abdullah Saad Abo Moati Company |
Joint Stock Company |
Al Yamamah Steel Company (Previous) |
Joint Stock Company |
National Gas and Industrialization Company (GASCO) (Previous) |
Joint Stock Company |
United Arab Company for Float Glass (Previous) |
Closed Joint
Stock Company |
Riyad Bank (Previous) |
Joint Stock Company |
Middle East Shipment Company – Emirate (Previous) |
Limited Company |
NSCSA AMERICA – USA (Previous) |
Limited Company |
Bahri Company (Previous) |
Joint Stock Company |
National Chemical Carriers Ltd. Co (Previous) |
Limited Company |
West of England Insurance Company –
Luxembourg (Previous) |
Limited Company |
International Shipowners Re (Previous) |
Limited Company |
Petradec Company for Gas Trade and
Transportation – (Previous) |
Limited Company |
ISRE Insurance Company – Luxembourg (Previous) |
Limited Company |
Independent |
Period from
11 May 2020 to
10 May 2023 |
Eng. Hussam
Al-Suwailem |
|
|
Independent |
Period from
11 May 2020 to
10 May 2023 |
Dr Peter Hugger |
Msg global solutions AG – Switzerland |
Private Company |
Echo Reinsurance Ltd. – Switzerland (Previous) |
Closed Joint
Stock Company |
Asia Capital Reinsurance Group Pte Ltd. –
Singapore (Previous) |
Private Company |
Msg Systems AG – Singapore (Previous) |
Private Company |
Gerling Global Re – Singapore (Previous) |
Closed Joint
Stock Company |
Executive Director |
Period from
11 May 2020 to
10 May 2023 |
Mr Fahad Al-Hesni |
Probitas Holdings (Bermuda) Ltd. |
Closed Joint
Stock Company |
Probitas Holdings UK Ltd. |
Closed Joint
Stock Company |
Probitas 1492 Services Ltd. |
Closed Joint
Stock Company |
12.6 Procedures
to inform
Board Members of shareholders' suggestions
and remarks
Saudi Re’s expert and professional Investor Relations function collates and analyzes suggestions and comments received from shareholders through communication channels or General Assembly Meetings
and submits findings to the
Board of Directors. For more information on the Company’s Investor Relations function and transparent engagement with stakeholders, please refer to the Corporate Governance section
of the ESG report, on page 59.
12.7 Powers and responsibilities of Board Committees
Executive Committee
The General Assembly shall approve, based on proposals by the Board of Directors the rules for the selection of Executive Committee members, the term of their membership and the method of the Committee work. The duties and responsibilities of the Executive Committee are as follows:
- Exercising the full powers and prerogatives of the Board between Board meetings and while the Board is not in session in cases where a quick action or resolution is required or warranted, except that the Committee shall not have the power to act in lieu of the full Board in any matter in respect of which the delegation of powers is prohibited under applicable law, or that requires the approval of the Company’s shareholders, or is specifically assigned to another committee of the Board.
- Reviewing the details of the Company’s business strategy and making recommendations to the Board for approval.
- Reviewing the details of the Company’s work plans and budget and regularly monitoring the progress of the work plan and budget.
- Overseeing the activities of the Chief Executive Officer of the Company.
- Supporting the Chief Executive Officer on an ad hoc basis to address specific needs or requirements. Reviewing alliances, mergers, acquisitions and other strategic agreements and making recommendations to the Board for approval.
- Taking any other action or assuming any other powers and responsibilities that may from time to time be assigned or delegated to it by the Board.
- Reviewing alliance, mergers, acquisition and other strategic agreements and making recommendations to the Board for approval.
|
Board
Member Name |
Nature of Membership |
1st
Meeting
17.02.2022 |
2nd
Meeting
20.03.2022 |
3rd
Meeting
15.05.2022 |
4th
Meeting
18.08.2022 |
5th
Meeting
30.10.2022 |
6th
Meeting
05.12.2022 |
Total
meetings
attended in
2022 |
1. |
Mr Hesham Al Shaikh |
Chairman |
|
|
|
|
|
|
4 |
2. |
Mr Fahad Al Hesni |
Member |
|
|
|
|
|
|
5 |
3. |
Mr Jean-Luc Gourgeon |
Member |
|
|
|
|
|
|
6 |
Audit Committee
The Board of Directors implement the rules for the selection of Audit Committee members which is approved by the General Assembly, also the scope of their membership and the method of the Committee work.
The duties and responsibilities of the Audit Committee should include the following:
- To supervise the Company’s Internal Audit Department to ensure its effectiveness in executing its activities and duties specified by the Board of Directors.
- To review the internal audit procedures and prepare a written report on such review including its recommendations.
- Reviewing audit plan of internal auditors and external auditors and make any comments thereon.
- Assessing the efficiency, effectiveness and objectivity of work performed by external auditors, Internal Audit Department or Internal Auditor and Compliance Control Department or Compliance Officer.
- Coordinating between internal and external auditors.
- Reviewing the internal and external auditors’ assessment of internal control procedures.
- Reviewing related parties’ transactions.
- Reviewing, approving and monitoring the implementation of compliance plan.
- To supervise the activities of the external auditors and approve any activity beyond the scope of the audit work assigned to them during the performance of their duties.
- To review the external auditor’s comments on the financial statements and follow up on the actions taken.
- Ensuring independence of external auditors from Company, Board Members and Senior Management.
- Discussing the annual and interim quarterly financial statements with external auditors and Company’s
Senior Management before issuance thereof.
- To review the interim and annual financial statements prior to presentation to the Board of Directors; and to give opinion and recommendations with respect thereto.
- To review the accounting policies in force and advise the Board of Directors of any recommendation thereto.
- Reviewing internal financial and non-financial controls and risk management system.
- Appointment and dismissal of Head of Internal Audit Department or Internal Auditor and Head of Compliance Control Department or Compliance Officer after obtaining SAMA No Objection, their performance evaluation and remunerations for all respective staff.
- Ensuring independence of Internal Audit Department or Internal Auditor and Compliance Control Department or Compliance Officer in performing tasks, and ensuring there is no restriction on their scope of work or any impediments that might negatively affect their work.
- Reviewing reports of Compliance Control Department or Compliance Officer and Internal Audit Reports and pursue the implementation of the recommended corrective measures and make necessary recommendations to Board.
- Reviewing the comments of SAMA and other relevant supervisory and control entities related to any regulatory violation or corrective actions requested and making recommendations thereon for the Board.
- Following up the reports issued by SAMA, and other relevant supervisory and control entities and making recommendations thereon to the Board.
- Monitoring the activities of Compliance Department and ensuring that Company’s compliance with SAMA, CMA and other laws and regulations.
- Reviewing the actuary reports and making recommendations thereon for the Board.
- Ensuring the Company’s compliance with the actuary’s proposals and recommendations where these are mandatory and required by regulations or SAMA instructions.
- Determining the monthly salary, bonus and other remuneration of the Internal Audit or Compliance Control Department or the Internal Auditor or Compliance Officer in accordance with the Company’s internal by-laws approved by the Board.
- Ensuring the Company has written code of conducts approved by its BOD to ensure that the Company’s activities are conducted in a fair and ethical manner.
- Following up on important lawsuits filed by or against Company and submitting period reports thereon to
the Boards.
- Ensuring optimal use and control of information technology necessary to generate reliable information and data is in place.
- Authority to investigate any activity within its terms of reference and have access to any information it may need.
- The report of the audit shall include details of its performance of its competencies and duties stated in the Companies Law and its Implementing Regulations, provided that the report contains its recommendations and opinion on the adequacy of the internal and financial control systems and risk management systems in the Company. The Board shall make available sufficient copies of the Audit Committee’s report at the Company’s head office, and publish them on the Company’s and the Exchange’s websites when publishing the invitation to convene the General Assembly, to enable shareholders to get a copy thereof. Summary of the report shall be read at the General Assembly.
- The Audit Committee shall develop arrangements that enable the Company’s employees to confidentially provide their remarks in respect of any inaccuracies in the financial or other reports. The Audit Committee shall ensure that such arrangements have been put into action through an adequate independent investigation in respect of the error or inaccuracy, and shall adopt appropriate follow-up procedures.
|
Board
Member Name |
Nature of Membership |
1st
Meeting
25.01.2022 |
2nd
Meeting
17.03.2022 |
3rd
Meeting
14.05.2022 |
4th
Meeting
19.07.2022 |
5th
Meeting
17.08.2022 |
6th
Meeting
27.09.2022 |
7th
Meeting
27.10.2022 |
8th
Meeting
04.12.2022 |
Total
meetings
attended
in 2022 |
1. |
Mr Hisham Al-Akil |
Ext. Chairman |
|
|
|
|
|
|
|
|
7 |
2. |
Dr Peter Hugger |
Member |
|
|
|
|
|
|
|
|
8 |
3. |
Mr Abdullah
Al Farraj |
Ext. Member |
|
|
|
|
|
|
|
|
8 |
4. |
Mr Tarik Zaino |
Ext. Member |
|
|
|
|
|
|
|
|
7 |
Investment Committee
The General Assembly shall approve, based on proposal by the Board of Directors, the rules for the selection of Investment Committee members, the term of their membership, and the method of the Committee’s work.
The duties and responsibilities of the Investment Committee are as follows:
- Ensuring that the Investment Policy Statement (IPS) is prepared in line with the overall business strategy of the Company as well as the regulatory guidelines.
- Obtaining Board approval for the IPS.
- Reviewing and revising the investment strategy on a quarterly basis taking changes in business requirements and market conditions into consideration.
- Appointment and evaluating the performance of Investment and Fund Managers.
- Recommending to the Board, the appointment and removal of Investment Advisor.
- Delegating when required execution of their decisions to a selected subcommittee and/or to the Management Team.
- Deciding the execution strategy for each segment of the investment portfolios, that is, whether the exposure in each segment will be executed via a passive or active management style, will be managed in-house or by external managers via segregated mandates or investment funds.
- Reviewing the decisions made by the Management Team and Investment Advisor(s).
- Taking any other action or assuming any other powers and responsibilities that may from time to time be assigned or delegated to it by the Board.
- Reporting to the Board, the performance of the Company’s investments in terms of risk, returns, and allocations and on any major pertinent developments.
|
Board
Member Name |
Nature of Membership |
1st Meeting
07.03.2022 |
2nd Meeting
09.05.2022 |
3rd Meeting
01.08.2022 |
4th Meeting
26.10.2022 |
5th Meeting
30.11.2022 |
Total meetings
attended in
2022 |
1. |
Mr Hesham Al-Shaikh |
Chairman |
|
|
|
|
|
0 |
2. |
Mr Mishari Al-Hussain |
Member |
|
|
|
|
|
5 |
3. |
Eng. Hussam Al-Suwailem |
Member |
|
|
|
|
|
5 |
4. |
Mr Abdulatif Al Fozan* |
Member |
|
|
|
|
|
1 |
* Mr. Abdulatif Al Fozan became an external member of the Investment committee on November 2022 by approval from the Saudi Central Bank “SAMA”.
Risk Committee
The General Assembly shall approve, based on proposal by
the Board of Directors, the rules for the selection of Risk Management Committee members, the term of their membership and the method of the Committee’s work.
The duties and responsibilities of the Risk Committee are as follows:
- Re-evaluating the Company’s risk appetite, tolerance,
and exposure to risk on a regular basis.
- Re-evaluating the Company’s risk management policy consistent with the Company’s commitments to shareholders and regulatory requirements.
- Supervising the implementation of necessary measures to mitigate identified risks.
- Understanding and reviewing the risks associated with the Company’s activities and maintaining an acceptable risk profile for the Company.
- Overseeing the risk management system and assessing its effectiveness, and ensuring infrastructure and resources are in place.
- Evaluation of the adequacy of the risk management function.
- Evaluating risks under certain stress scenarios (e.g. rating downgrade, capital issues, regulatory breaches/fines etc).
- Reviewing, and evaluating Business Continuity Plan Framework and Policy.
- Reviewing and obtaining Board approval for the following cybersecurity governance documentation:
- Cybersecurity Committee Charter.
- Cybersecurity Governance Framework
- Cybersecurity strategy
- Cybersecurity policy
- Ensuring the cybersecurity risks of the Company is well managed.
- Reviewing catastrophic exposure limit.
- Review threshold limits of business portfolios.
- Reviewing capital adequacy and solvency of the Company.
- Reviewing ALM processes and activities on a regular basis.
- Review on regular basis regulatory, compliance and AML risks.
- Reviewing periodic reports from Risk Management Department, such as Quarterly Risk Management reports.
- Taking any other action or assuming any other powers and responsibilities that may from time to time be assigned or delegated to it by the Board.
The Committee shall have the authority to obtain advice and assistance from internal or external legal, actuarial, accounting or other advisors and to approve the fees and other retention terms related to any such external counsel, consultants and advisors.
|
Board
Member Name |
Nature of Membership |
1st Meeting
09.03.2022 |
2nd Meeting
15.05.2022 |
3rd Meeting
02.08.2022 |
4th Meeting
29.10.2022 |
5th Meeting
30.11.2022 |
Total meetings
attended in
2022 |
1. |
Mohamad Al-Otaibi |
Chairman |
|
|
|
|
|
5 |
2. |
Dr Peter F Hugger |
Member |
|
|
|
|
|
5 |
3. |
Dr Volker Lauff |
Ext. Member |
|
|
|
|
|
5 |
Technical Committee
The General Assembly shall approve, based on proposal by the Board of Directors, the rules for the selection of Technical Committee members, the term of their membership and the method of the Committee work.
The duties and responsibilities of the Technical Committee should include the following:
- Reviewing underwriting policies and guidelines.
- Reviewing pricing methodologies and tools used to price/rate risks.
- Reviewing the underwriting performance quarterly.
- Reviewing the claims activities quarterly.
- Reviewing the business plan assumptions annually and recommending the underwriting business plans
to the Board.
- Recommending for Board approval new lines of business.
- Reviewing and recommending for Board approval the territories in which company should or should not write business from.
- Defining the Company’s retrocession structure and recommending for Board approval including the
retro cost.
- Ensuring that the securities of the retro panel are within the regulatory requirements and any changes are evaluated
and necessary actions taken.
- Re-evaluating the Company’s retrocession structure on a regular basis.
- Taking any other action or assuming any other powers and responsibilities that
may from time to time be assigned or delegated to it
by the Board.
The Committee shall have the authority to obtain advice and assistance from internal or
external legal, accounting or
other advisors and to approve
the fees and other retention terms related to any such external counsel, consultants and advisors.
|
Board Member Name |
Nature of Membership |
1st
Meeting
03.01.2022 |
2nd
Meeting
11.01.2022 |
3rd
Meeting
08.03.2022 |
4th
Meeting
17.04.2022 |
5th
Meeting
09.06.2022 |
6th
Meeting
29.06.2022 |
7th
Meeting
03.08.2022 |
8th
Meeting
26.09.2022 |
9th
Meeting
26/25.10.2022 |
10th
Meeting
29.11.2022 |
Total
meetings
attended
in 2022 |
1. |
Jean-Luc Gourgeon |
Chairman |
|
|
|
|
|
|
|
|
|
|
10 |
2. |
Marc
Maupoux |
Member |
|
|
|
|
|
|
|
|
|
|
9 |
3. |
Ahmad Sabbagh |
Member |
|
|
|
|
|
|
|
|
|
|
10 |
4. |
Turki
Al-Sudairy* |
Member |
|
|
|
|
|
|
|
|
|
|
1 |
* Mr. Turki Al Sudairy became an external member of the Technical committee on November 2022 by approval from the Saudi Central Bank “SAMA”.
Nomination and Remuneration Committee
The General Assembly shall approve, based on proposal by the Board of Directors, the rules for the selection of Nomination and Remuneration Committee members, the term of their membership and the method of
the Committee’s work.
The duties and responsibilities of the Nomination and Remuneration Committee should include the following:
Recommending to the Board appointments to membership
of the Board and its committees in accordance with the approved policies and standards. The Committee shall ensure that
no person who has been previously convicted of any offense affecting honor or honesty is nominated for such membership.
- Preparing a description of the required capabilities and qualifications for the membership of the Board and its committees, including the time that a Board Member should set aside for carrying out the duties of the Board and its committees.
- Setting procedures to be followed if the position of a member of the Board or a Senior Executive becomes vacant.
- Reviewing at least annually
the requirement and availability of suitable skills within the membership of the Board and recommending remedies that are in the Company’s best interest.
- Recommending succession planning policies to the Board and committees.
- Reviewing the structure of the Board and its committees and determining their points of weakness and recommending changes where needed. Also providing job descriptions for the Executive, Non-Executive and Independent Directors and the Senior Executive Management.
- Assessing and monitoring the independence of the independent Board and Board committee members at least on an annual basis and ensuring that no conflict of interest exists in the cases where a Board Member also acts as a member of the Board of another company.
- Drawing clear policies regarding the compensation, remunerations and indemnities of the Board (as approved by the General Assembly) its committees, CEO, and Senior Management employees based on their performance in achieving the Company’s strategic objectives and risk adjusted profits.
- Ensuring that an annual review of remuneration and compensation plans for members of Senior Management is conducted independently of Executive Management.
- Making the final recommendations to the
Board with regards to
selecting members of the Senior Management and/or promoting current employees to Senior Management positions as per SAMA’s
Fit and Proper rules.
- Making the final recommendations to the
Board with regards to dismissing members of the Senior Management.
- Establishing a succession policy and procedure for the CEO and other key members of Senior Management and monitoring the implementation of the succession plans and process.
- Evaluate the performance of the Board (overall and individual performance) and its committees in a regular basis (at least on an annual basis.
- Overseeing the induction programs and training programs for Board Members.
- Taking any other action or assuming any other powers and responsibilities that may from time to time be assigned or delegated to it by the Board.
|
Board
Member Name |
Nature of
Membership |
1st Meeting
20.01.2022 |
2nd Meeting
28.02.2022 |
3rd Meeting
16.03.2022 |
4th Meeting
12.05.2022 |
5th Meeting
04.08.2022 |
6th Meeting
03.11.2022 |
Total
meetings
attended
on 2022 |
1. |
Marc Maupoux |
Committee |
|
|
|
|
|
|
6 |
2. |
Mishari Al-Hussain |
Member |
|
|
|
|
|
|
6 |
3. |
Mohamad Al-Otaibi |
Member |
|
|
|
|
|
|
6 |
4. |
Ahmed Sabbagh |
Member |
|
|
|
|
|
|
6 |
12.8 Responsibilities of the Board of Directors
The important functions of the Board are as follows:
- Providing strategic guidance to the Company, including setting objectives and formulating strategic plans.
- Supervising the implementation of strategic plans and major transactions and determining the most appropriate capital structure for the Company, its strategies and financial objectives, and approving all kinds of estimated budgets;
- Approving key policies and procedures and regularly reviewing and updating them.
- Establishing and monitoring the Company’s internal control system and ensuring its adequacy and effectiveness.
- Establishing and monitoring a risk management system, where risks are assessed, managed, and monitored on
a continuous basis.
- Selecting and changing
(if needed) executives in key positions, and ensuring that
the Company has an appropriate replacement policy for their replacement by an appropriate alternative with
the necessary skills and eligibility for the office.
- Supervising Senior Management and monitoring the Company’s performance against the performance objectives set by the Board.
- Ensuring the integrity of the Company’s accounting and financial reporting system and the appropriateness of its disclosure process.
- Ensuring that the interests of the policyholders are being protected at all times.
- Promoting higher standards of corporate governance and ensuring compliance with applicable laws and regulations at all times.
- Promoting a culture of good corporate governance and high ethical standards.
- Granting Audit Committee the appropriate level of authority to investigate any matter within its mandate and shall ensure that the internal audit function is autonomous and is granted full access to all the information it needs to conduct its activities. In addition, the Board should take all necessary measures to ensure the responsiveness of Senior Management to internal auditors’ queries and recommendations.
- The Board shall, based upon a proposal from the Audit Committee, develop the necessary policies and procedures to be followed by stakeholders when submitting complaints or reporting any violations, facilitating the method by which stakeholders (including company employees) report to the Board conducts and practices of the Executive Management’s that violate applicable laws, regulations and rules or raising doubts as to the financial statements or the internal audit controls or others, whether such conducts or practices are against them or not, and conducting the necessary investigation in that regard; also maintaining the confidentiality of reporting procedures through facilitating direct contact with an independent member of the Audit Committee or other specialized committees; appointing an employee to receive and address complaints or reports sent by stakeholders; dedicating a telephone number or an email address for receiving complaints; and providing the necessary protection to the stakeholders.
12.9 Attendance record of Board Meetings during 2022
Board Member Name |
Designation |
1st
Meeting
held on
17.02.2022 |
2nd
Meeting
held on
20.03.2022 |
3rd
Meeting
held on
05.04.2022 |
4th
Meeting
held on
28.04.2022 |
5th
Meeting
held on
15.05.2022 |
6th
Meeting
held on
09.06.2022 |
7th
Meeting
held on
16.06.2022 |
8th
Meeting
held on
28/29.06.2022 |
9th
Meeting
held on
18.08.2022 |
10th
Meeting
held on
30.10.2022 |
11th
Meeting
held on
05.12.2022 |
Total
meetings
attended
in 2022 |
Mr Hesham
Al-Shaikh |
Chairman |
|
|
|
|
|
|
|
|
|
|
|
7 |
Mr Mishari
Al-Hussain |
Vice Chairman |
|
|
|
|
|
|
|
|
|
|
|
11 |
Mr Fahad
Al-Hesni |
MD/CEO |
|
|
|
|
|
|
|
|
|
|
|
10 |
Mr Ahmad Sabbagh |
Member |
|
|
|
|
|
|
|
|
|
|
|
11 |
Mr Mohamad Al-Otaibi |
Member |
|
|
|
|
|
|
|
|
|
|
|
11 |
Mr Jean-Luc Gourgeon |
Member |
|
|
|
|
|
|
|
|
|
|
|
11 |
Mr Marc Maupoux |
Member |
|
|
|
|
|
|
|
|
|
|
|
10 |
Dr Peter Hugger |
Member |
|
|
|
|
|
|
|
|
|
|
|
11 |
Eng. Hussam Al-Suwailem |
Member |
|
|
|
|
|
|
|
|
|
|
|
11 |
12.10 Attendance record of General Assembly Meetings during 2022
|
Name |
Attendance Record |
Ordinary General
Assembly Meeting
23/07/1443 – 24 Feb. 2022 |
Ordinary General
Assembly Meeting
10/10/1443 – 11 May 2022 |
Extraordinary General
Assembly Meeting
16/02/1444 – 12 Sep. 2022 |
1. |
Hesham Al-Shaikh (Chairman) |
|
|
|
2. |
Mishari Al-Hussain (Vice Chairman) |
|
|
|
3. |
Fahad Al-Hesni |
|
|
|
4. |
Mohammad Al-Otaibi |
|
|
|
5. |
Ahmed Sabbagh |
|
|
|
6. |
Jean-Luc Gourgeon |
|
|
|
7. |
Eng. Hussam Al-suwailem |
|
|
|
8. |
Dr Peter Hugger |
|
|
|
9. |
Marc Maupoux |
|
|
|
12.11 Performance of the Board and
its committees
Board effectiveness evaluation
The Board and Committees undergo regular performance assessment using tools and forms approved by the Nomination and Remuneration Committee.
In addition, the Company contracted a consultant to assess the level and standard of governance amongst Board members. Recommendations of the assessment were taken into consideration, and the Board took all necessary steps to address the outcomes of the consultant’s assessment. The Board made several decisions to adopt changes in its policies and procedures, in addition to introducing new programs and systems that will strengthen its governance.
12.12 Results of the annual review of effectiveness of the internal control procedures of the Company and the opinion of the Audit Committee with respect to adequacy of Company’s internal control system
The Company’s internal control system intends to ensure that control and monitoring tools are in place to ensure, at a reasonable level, the soundness of financial report and mitigation of risk. The results of annual audit conducted by the internal auditor have not revealed any material deficiency or weakness on the Company’s internal control system.
The Audit committee confirms that there was no conflict between the audit committee resolutions.
12.13 Remuneration of Board Members and Executive Management
The General Assembly has approved on 21 July 2021 an amended remuneration policy for the Board and members of committees and Executive Management. According to the policy, each member is entitled to SR 5,000 for each attended meeting of the Board and any Board committee meeting. The Company’s Board Directors are entitled to a minimum amount of SR 200,000 as an annual remuneration against Board directorship and contribution to Board business. The Chairman of the Board is entitled to a minimum amount of SR 300,000 per year. Each Non-Board Member is entitled to an amount of SR 5,000 as an attendance fee per meeting per committee and is entitled to
a lump sum of SR 100,000 per year as a remuneration for contribution to the Committee functions. The Chairman of the Audit Committee is also entitled
to an amount of SR 120,000.
The remunerations of the members of the Board of Directors and its committees are presented to the Company's General Assembly
for approval.
(SR ’000) |
BOD Members
(Executives) |
BOD Members
(Non-Executive
and
Independent) |
Five Top
Executives
including
CEO and CFO |
Salaries and benefits |
– |
– |
9,600.00 |
Annual compensation |
200.00 |
1,700.00 |
2,230.00 |
Meeting fees and expenses |
75.00 |
870.00 |
– |
Consultancy fees |
– |
189.00 |
– |
Benefits in kind granted monthly or yearly |
– |
– |
– |
Total |
275.00 |
2,759.00 |
11,830.00 |
Board Member name |
|
BOD
meetings
SR |
EXCOM
meetings
SR |
INVST
COM
meetings
SR |
TC COM
meetings
SR |
Audit
COM
meetings
SR |
RMC
meetings
SR |
N&R
COM
meetings
SR |
Total
meetings
fees
SR |
BOD
Remuneration
SR |
Total
amount to
be paid
SR |
Mr Hesham Al-Shaikh |
Chairman |
35,000 |
20,000 |
– |
– |
– |
– |
|
55,000 |
300,000 |
355,000 |
Mr Fahad Al-Hesni |
CEO/MD |
50,000 |
25,000 |
|
– |
– |
– |
– |
75,000 |
200,000 |
275,000 |
Mr Mishari Al-Hussain |
Director |
55,000 |
|
25,000 |
– |
– |
– |
30,000 |
110,000 |
200,000 |
310,000 |
Mr Ahmed Sabbagh |
Director |
55,000 |
– |
– |
50,000 |
– |
– |
30,000 |
135,000 |
200,000 |
335,000 |
Mr Jean-Luc Gourgeon |
Director |
55,000 |
30,000 |
– |
50,000 |
– |
– |
|
135,000 |
200,000 |
335,000 |
Mr Mohammad Al-Otaibi |
Director |
55,000 |
– |
– |
– |
– |
25,000 |
30,000 |
110,000 |
200,000 |
310,000 |
Mr Marc Maupoux |
Director |
50,000 |
– |
– |
45,000 |
– |
– |
30,000 |
125,000 |
200,000 |
325,000 |
Dr Peter Hugger |
Director |
55,000 |
– |
– |
– |
40,000 |
25,000 |
– |
120,000 |
200,000 |
320,000 |
Eng. Hussam Al-Suwailem |
Director |
55,000 |
– |
25,000 |
– |
– |
– |
– |
80,000 |
200,000 |
280,000 |
|
Total |
465,000 |
75,000 |
50,000 |
145,000 |
40,000 |
50,000 |
120,000 |
945,000 |
1,900,000 |
2,845,000 |
External Committee
member |
|
BOD
meetings
SR |
EXCOM
meetings
SR |
INVST
COM
meetings
SR |
TC COM
meetings
SR |
Audit
COM
meetings
SR |
RMC
meetings
SR |
N&R
COM
meetings
SR |
Total
meetings
fees
SR |
BOD
Remuneration
SR |
Total
amount to
be paid
SR |
Mr Hisham Al-Akil |
External Chairman
Audit Committee |
|
|
– |
|
35,000 |
– |
|
35,000 |
120,000 |
155,000 |
Dr Volker Lauff |
External Member
Risk Committee |
|
|
– |
|
|
25,000 |
|
25,000 |
100,000 |
125,000 |
Mr Abdullah Al-Farraj |
External Member
Audit Committee |
|
|
– |
|
40,000 |
– |
|
40,000 |
100,000 |
140,000 |
Mr Tarik Zaino |
External Member
Audit Committee |
|
|
– |
|
35,000 |
– |
|
35,000 |
100,000 |
135,000 |
Mr Turki Al-Sudairy |
External member
of Technical Committee |
|
|
|
5,000 |
|
|
|
5,000 |
10,411 |
15,411 |
Mr Abdulatif Al Fozan |
External member
of Investment Committee |
|
|
5,000 |
|
– |
– |
|
5,000 |
10,411 |
15,411 |
|
Total |
|
|
5,000 |
5,000 |
110,000 |
25,000 |
|
145,000 |
440,822 |
555,000 |
|
Grand Total |
465,000 |
75,000 |
55,000 |
150,000 |
150,000 |
75,000 |
120,000 |
1,090,000 |
2,340,822 |
3,400,000 |
12.14 Sanctions, penalties, precautionary restrictions imposed by regulatory authorities
Sanction/penalty/
Precautionary procedure/
Preventive measure |
Reasons for violation |
Imposing
authority |
Measures undertaken
to remedy and avoid
such non-compliance
in the future |
Incorrect
Disclosure |
Based on Saudi Re's announcement for the
unaudited financial report for Q1 of the year 2022
CMA saw that The special justification for the high (decrease) of net profit during the current profit compared to the same quarter of the previous year
was found to be inconsistent with the figures mentioned in the items. |
Capital market authority |
Policy has been modified to reflect two users. First user is a submitter and the second user is a reviewer. |
Violation of Saudi Central Bank’s supervisory and control instructions |
Delay in delivering the results of the second trial
run related to the fourth stage of the transition
plan to IFRS No. 17 |
Saudi Central Bank |
Submit all trail runs on time |
Subject of the penalty |
2022 |
2021 |
|
Number of
resolutions |
Sum
total
for the
penalty in
SR |
Number
of
resolutions |
Sum total
for the
penalty in
SR |
Violation of Saudi Central Bank’s supervisory and control instructions* |
1 |
20,000 |
1 |
0 |
Violation of Saudi Central Bank’s customer protection instructions |
0 |
0 |
0 |
0 |
Violation of Saudi Central Bank’s instructions on AML and CTF |
0 |
0 |
0 |
0 |
*Reason: Delay in delivering the results of the second trial run related to the fourth stage of the transition plan to IFRS No. 17
12.15 The Company’s significant plans, decisions, and
future expectations
- Approval of Appointment of Labuan Branch External Auditor.
- Approval of the annual
financial statement ending 31 December 2021, and quarterly financial statements ending 31 March 2022, 30 June 2022 and
30 September 2022 including Technical Reserves.
- Approval of Recommendation to Extraordinary General Assembly the Capital Increase by Way of Rights Issue and the appointment of Financial Advisor for the Rights Issue.
- Approval of appointment of external members to Board Investment and Technical Committees.
- Approval of and recommendation to the Extraordinary General Assembly the amendment of the Article of Association to increase the Board Seats.
- Approval of updated Rewards Strategy for Employees.
- Approval of Retrocession Appropriateness Report submitted by the Appointed Actuary.
- Approval of renewal of Appointed Actuary assignment.
- Approval to renew the provision of Reinsurance cover to Probitas Corporate Capital Ltd. for its participation in Lloyds Syndicate 1492 for the year
of Account 2023.
- Approval of and recommendation to the Extraordinary General Assembly the amendment of the Article of Association Shares Buy-back.
- Approval of the non-life retrocession program for 2022/23 and life retrocession program for 2023.
- Approval of the 2023 Business Plan and Budgets.
- Approval of charters and policies including Corporate Governance Policy, Board Succession Policy, Human Resources Policy and Investment Policy Statement.
12.16 Details of Affiliate Company
Affiliate name |
Capital |
Company’s
ownership
percentage |
Main scope of
business |
Country of
operation |
Country of
incorporation |
Probitas Holding Ltd. |
4.508.982 USD |
49.9 |
Insurance |
United Kingdom |
Bermuda |
Interest in a class of voting shares held by persons (other than the Company’s Directors, Senior Executives and their relatives) who have notified the Company of their holdings pursuant to Article
(45) of the Listing Rules, along with any change to such rights during the last fiscal year
|
Name of the person
of interest |
Number of shares at the
beginning of the year
% |
Number of shares at the
end of the year
% |
Net
change |
Change
ratio
% |
1. |
Ahmad Hamad Algosabi
& Bros. Company |
5 |
5 |
0 |
0 |
Details of any interest, contractual securities or rights issue of the Board members and their relatives on the shares or debt instruments of the Company or its affiliates, and any change on such interest or rights during the last fiscal year
|
Names of the
persons of interest |
Beginning of the year |
End of the year |
Net
change |
Change
ratio
% |
Number of
shares |
Percentage of
ownership |
Debt
instruments |
Number of
shares |
Percentage of
ownership |
Debt
instruments |
1. |
Hesham Al-Sheikh
(Chairman) |
8,910 |
0.010 |
0 |
8,910 |
0.010 |
0 |
0 |
0 |
2. |
Mishari Al-Hussain
(Vice Chairman) |
4,455 |
0.005 |
0 |
4,455 |
0.005 |
0 |
0 |
0 |
3. |
Fahad Al-Hesni |
55,000 |
0.062 |
0 |
55,000 |
0.062 |
0 |
0 |
0 |
4. |
Mohammad Al-Otaibi |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5. |
Ahmed Sabbagh |
356,400 |
0.400 |
0 |
356,400 |
0.400 |
0 |
0 |
0 |
6. |
Jean-Luc Gourgeon |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7. |
Eng. Hussam Al-Suwailem |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
8. |
Dr Peter Hugger |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9. |
Marc Maupoux |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Details of any interest, contractual securities or rights issue of the Senior Executives and their relatives on the shares or debt instruments of the Company or its affiliates, and any change on such interest or rights during the last fiscal year
|
Names of the
persons of interest |
Beginning of the year |
End of the year |
Net
change |
Change
ratio
% |
Number of
shares |
Percentage of
ownership |
Debt
instruments |
Number of
shares |
Percentage of
ownership |
Debt
instruments |
1. |
Fahad Al-Hesni |
55,000 |
0.062 |
0 |
55,000 |
0.062 |
0 |
0 |
0 |
2. |
Ahmed Al-Jabr |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3. |
Nilmin Pieries |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4. |
Fadi Al-Qutub |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5. |
Ahmed Al- Qarishi |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12.17 Information on any loans, and amounts paid by the Company in repayment of loans during the year
|
Creditor’s name |
Amount of
principal debt |
Loan
term |
Amounts paid by the
Company in repayments
of loans during the year |
Remaining
amount |
Total indebtedness
of Company and its
affiliates |
1. |
Arqaam capital |
56,797,019 |
Open ended with annual renewal |
1,207,363 |
56,797,019 |
56,797,019 |
12.18 The Company’s requests of shareholders registry, dates, and
reasons thereof
Number of the
Company’s requests of shareholders registry |
Request date |
Request reasons |
|
|
|
1. |
03 January 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
2. |
02 February 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
3. |
24 February 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right and to prepare for the General Assembly Meeting convened on 24/02/2022 |
4. |
02 March 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
5. |
04 April 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
6. |
09 May 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
7. |
11 May 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right and to prepare for the General Assembly Meeting convened on 11/05/2022 |
8. |
02 June 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
9. |
28 June 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
10. |
03 July 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
11. |
02 August 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
12. |
04 September 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
13. |
12 September 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right and to prepare for the General Assembly Meeting convened on 12/09/2022 |
14. |
03 October 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
15. |
02 November 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
16. |
08 November 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
17. |
04 December 2022 |
To comply with Article number 38 of the Implementing Regulations of the Cooperative Insurance Companies Control Law and to calculate the differences in the shareholder right |
12.19 Transactions between the Company and related parties
- Reinsurance contracts for one year with Probitas Corporate Capital Ltd, which is owned by Probitas Holding (Bermuda) Limited, and has an indirect interest for the Chairman of the Board of Directors Mr Hisham Abdulmalik Al-Shaikh, MD/CEO
Mr Fahad Al-Hesni and Board Member Mr Jean-Luc Gourgeon for their membership in the Board of Directors of the parent company Probitas Holding (Bermuda) Ltd. Also, there is an indirect interest for Board Member Mr Jean-Luc Gourgeon and the CFO Mr Nilmin Pieries for their membership in the Board of Directors of Probitas Corporate Capital Ltd. noting that the value of transactions during 2022 is estimated at SR 158,704,085 with no preferential conditions.
- A consultancy services contract for one year with the Board Member Mr Jean-Luc Gourgeon, who has a direct interest, with a contract value of SR 188,983 and no preferential conditions during 2022.
During 2022 there have not been:
- Any arrangement or agreement under which a Director or a Senior Executive of the Company has waived any remuneration.
- Any arrangement or agreement under which a shareholder of the Company has waived any rights to dividends.
Investments or reserves for the benefit of employees
The Company has not made any investments or reserves for the benefit of its employees.
The external auditor's report does not contain any reservations on the financial statements, nor has the Board made any recommendation to replace the auditor before the end of the term.
12.20 Declaration
- It has no convertible debt instruments, contractual securities, preemptive right
or similar rights issued or granted by the Company during the financial year
ended 31 December 2022.
- here have not been any conversion or subscription rights under any convertible debt instruments, contractually based securities, warrants or similar rights issued or granted by the Company during 2022.
- There have not been any, redemption, purchase or cancellation by the Company of any redeemable debt instruments and the value of such securities outstanding.
- During 2022, there have not been any arrangement or agreement under which a Director or a Senior Executive of the Company has waived any remuneration.
- During 2022, there is no business or contract to which the Company is a party and in which a Director of the Company, a Senior Executive or any person related to any of them is or was interested. Other than the contracts mentioned in the item (Transactions) between the Company and related parties) here above.
- There no competing business with the Company or any of its activities that any member of the Board is engaging in or was engaging in such competing businesses.